TRISHNA PATEL: Open Payments
NPI 1801668082 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,519 in 165 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $3,098 · 2025 $2,519
Food & beverage: $2,519
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $452 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 26 | $362 |
| Neurocrine BioSciences, Inc. | 22 | $353 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $244 |
| Otsuka America Pharmaceutical, Inc. | 14 | $214 |
| Lundbeck LLC | 12 | $168 |
| Janssen Pharmaceuticals, Inc | 8 | $139 |
| Axsome Therapeutics, Inc. | 9 | $135 |
| Almatica Pharma LLC | 5 | $105 |
| E.R. Squibb & Sons, L.L.C. | 2 | $64 |
Products named: VRAYLAR, REXULTI, CAPLYTA, INGREZZA, TRINTELLIX, Auvelity, LOREEV XR, INVEGA SUSTENNA.
Industry payments across SC — which companies pay providers there.
